维普期刊资源整合服务平台（V6.5）

156篇 您的检索式：作者名="GISH RG"

选中清除导出查看参考文献查看引证文献引用追踪共8页首页上一页第1页下一页末页 /8 跳转

	题名	作者	年代	出处	被引量
1	A dose- ranging study of the efficacy and tolerability of entecavir in lamivudine - refractory chronic hepatitis B patients 显示文摘	Chang TT Gish RG Hadziyannis SJ	2005	Gastroenterlogy2005，129，8：	1
2	Dose range study of pharmacokinetics, safety, and preliminary antiviral activity of emtricitabine in adults with hepatitis B virus infection显示文摘	Gish RG Leung NW Wright TL	2002	Antimicrob Agents Chemother2002，46，6：	1
3	Immunoregulatory cytokinesin chronic hepatitis C virus infection:pre-and posttreatment with interferon alpha显示文摘	Cacciarelli TV Martinez OM Gish RG	1996	Hepatology1996，24，1：	1
4	A comparison of entecavir and lamivudine for HbeAg - positive chronic hepatitis B显示文摘	Chang TT Gish RG de Man R	2006	N Engl J Med2006，354，12：	1
5	A dose-ranging study of the efficacy and tolerability of entecavir in Lamivudine-refractory chronic hepatitis B patients显示文摘	Chang TT Gish RG Hadziyannis SJ	2005	Gastroenterology2005，129，4：	1
6	Hepatocellular carcinoma: molecular and genomie guideline for the clinician显示文摘	Frenette C Gish RG	2011	Clin Liver Dis2011，15，2：	1
7	Genotyping and genomic sequencing in clinical practice显示文摘	Gish RG Locamini S	2007	Clin Liver Dis2007，11，4：	1
8	Application of six hepatitis C virus genotypingsystems to sera from chronic hepatitis C patients in the United State显示文摘	Lau JY Mizokami KL Gish RG	1995	J Infect Dis1995，171，：	1
9	A dose -ranging study ofthe efficacy and tolerability of entecavir in lamivudine -refractorychronic hepatitis B patient显示文摘	Chang TT Gish RG Hadziyannis SJ	2005	Gastroenterology2005，129，4：	1
10	Concordance between hepatitis C virus serotyping assays显示文摘	Gish RG Qian KP Quan S	1997	J ViralH epat1997，4，6：	1
11	A compareson of entecavir and lamivudine for HBeAg -positive chronic hepatitis B显示文摘	CHANG TT GISH RG DE MAN R	2006	N Engl J Med2006，354，：	1
12	A comparison of entecavir and lamivudine for HBeAg-positive chronic hepatitis B显示文摘	Gish RG de Man R	2006	N Engl J Med2006，354，10：	1
13	A comparison of entecavir and lamivudine for HBeAg positive chronic hepatitis B显示文摘	CHANG TT GISH RG de MAN R	2006	N Engl J Med2006，354，：	1
14	Hepatocellular carcinoma (HCC):current and evolving therapies显示文摘	Gish RG Baron A	2008	Idrugs2008，11，3：	1
15	Characterics of hepatitis B virus laolatos of genotype G and their phylogenetic differences from the other six genotypes (A through F)显示文摘	Kato H Orito E Gish RG	2002	Virus2002，76，12：	1
16	A comparison of entecavir and lamivudine for HBeAg-positive chronic hepatitis B显示文摘	Chang TT Gish RG de Man R	2006	N Engl J Med2006，354，10：	1
17	Chronic hepatitis B: current testing strategies 显示文摘	Gish RG Locarnini SA	2006	Clin Gastteriebtero Hepatol2006，4，6：	1
18	Current treatment and future directions in the management of chronic hepatitis B viral infeetion显示文摘	Gish RG	2005	Clin Liver Dis2005，9，：	1
19	Safety and antiviral activity of emtricitabine (FTC) for the treatment of chronic hepatitis B infection:a two-year study显示文摘	Gish RG Trinh H Leung N	2005	J Hepatol2005，43，1：	1
20	The degree of readiness of selected biomarkers for the early detection of hepatocellular carcinoma:notes from a recent workshop显示文摘	Block TM Marrero J Gish RG	2008	Cancer Biomark2008，4，1：	1

返回顶部每页显示：

共8页首页上一页第1页下一页末页 /8 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示